Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 13,056 shares at $69.42 ($893K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Seasonal sale ($893k) by Chief Commercial Officer — this insider has traded TARS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 4,286 | $298K | 33.3% |
| 2 | $68.71 | 4,330 | $298K | 33.3% |
| 3 | $67.00 | 4,440 | $297K | 33.3% |
| Total | $68.36 avg | 13,056 | $893K | 100% |
| Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |
| TARS | SELL | 2023-06-12 | $2K | — | Filing → |